Cadrenal Therapeutics CVKD
NASDAQ CVKD
$0.98 -0.04 (-4.24%)
As of: Oct 22, 2026 · 2:20 PM EDT

Cadrenal Therapeutics (CVKD) EBT (2022 - 2026)

Updated

Cadrenal Therapeutics' EBT was -$3.32 million in Q2 2026, compared with -$3.67 million a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) EBT (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cadrenal Therapeutics' EBT was -$11.79 million through Jun 30, 2026; for FY2023, it came in at -$7.38 million.

  • In earlier years, EBT was -$2.74 million in FY2022.
  • The Q2 2026 figure marks the highest quarterly EBT since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,167.12 Bn 1,135.70 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 647.48 Bn 567.35 Bn 17.30 Bn 34.00 Mn
3 AbbVie 502.73 Bn 475.84 Bn 12.70 Bn 4.28 Bn
4 Merck 363.86 Bn 318.23 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 303.31 Bn 267.30 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 269.08 Bn 242.77 Bn 12.86 Bn 2.80 Bn
7 Amgen 242.07 Bn 197.46 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 194.93 Bn 169.12 Bn 6.22 Bn -10.25 Bn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn -653.00 Mn
10 Cadrenal Therapeutics 2.85 Mn -9.77 Mn - -3.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.32 Mn
Jun 30, 2025 -3.67 Mn
Sep 30, 2024 -2.41 Mn
Jun 30, 2024 -2.39 Mn
Mar 31, 2024 -1.66 Mn
Dec 31, 2023 -1.14 Mn
Sep 30, 2023 -1.04 Mn
Jun 30, 2023 -1.00 Mn
Mar 31, 2023 -4.20 Mn
Dec 31, 2022 -1.09 Mn
Sep 30, 2022 -986,332.00
Jun 30, 2022 -488,793.00
Mar 31, 2022 -172,602.00
API Access

Cadrenal Therapeutics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=CVKD&period=max&api_key=YOUR_API_KEY